Windtree Therapeutics(WINT) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates WARRINGTON, PA – November 27, 2024 – Windtree Therapeutics, Inc. ("Windtree" or "the Company") (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the third quarter ended September 30, 2024 and provided key business updates. "The third quarter of 2024 was marked with significant pro ...